Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?
about
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Is Ki67 still a powerful ally ...... atment of early breast cancer?
@en
Is Ki67 still a powerful ally ...... atment of early breast cancer?
@nl
type
label
Is Ki67 still a powerful ally ...... atment of early breast cancer?
@en
Is Ki67 still a powerful ally ...... atment of early breast cancer?
@nl
prefLabel
Is Ki67 still a powerful ally ...... atment of early breast cancer?
@en
Is Ki67 still a powerful ally ...... atment of early breast cancer?
@nl
P2860
P1476
Is Ki67 still a powerful ally ...... atment of early breast cancer?
@en
P2093
Andrea Rocca
Giuseppe Bronte
P2860
P2888
P356
10.1007/S10549-017-4630-9
P407
P577
2018-01-06T00:00:00Z